36282-74-3

Upstream product

• 1624-54-0 2-{(E)-[(2-hydroxyphenyl)imino]methyl}phenol 
• 90-02-8 salicylaldehyde 
• 95-55-6 2-amino-phenol 
• 1761-56-4 2-[[(2-hydroxyphenyl)imino]methyl]phenol 

Downstream Products

• 1426561-57-0 2-(((2-hydroxybenzyl)(2-hydroxyphenyl)amino)methyl)-4-nitrophenol 

Relevant academic research and scientific papers

Inhibition of copper-mediated aggregation of human γD-crystallin by Schiff bases

Abstract: Protein aggregation, due to the imbalance in the concentration of Cu2+ and Zn2+ ions is found to be allied with various physiological disorders. Copper is known to promote the oxidative damage of β/γ-crystallins in aged eye lens and causes their aggregation leading to cataract. Therefore, synthesis of a small-molecule ‘chelator’ for Cu2+ with complementary antioxidant effect will find potential applications against aggregation of β/γ-crystallins. In this paper, we have reported the synthesis of different Schiff bases and studied their Cu2+ complexation ability (using UV–Vis, FT-IR and ESI-MS) and antioxidant activity. Further based on their copper complexation efficiency, Schiff bases were used to inhibit Cu2+-mediated aggregation of recombinant human γD-crystallin (HGD) and β/γ-crystallins (isolated from cataractous human eye lens). Among these synthesized molecules, compound 8 at a concentration of 100 μM had shown ~95% inhibition of copper (100?μM)-induced aggregation. Compound 8 also showed a positive cooperative effect at a concentration of 5–15 μM on the inhibitory activity of human αA-crystallin (HAA) during Cu2+-induced aggregation of HGD. It eventually inhibited the aggregation process by additional ~20%. However, ~50% inhibition of copper-mediated aggregation of β/γ-crystallins (isolated from cataractous human eye lens) was recorded by compound 8 (100 μM). Although the reductive aminated products of the imines showed better antioxidant activity due to their lower copper complexing ability, they were found to be non-effective against Cu2+-mediated aggregation of HGD. Graphical Abstract: [Figure not available: see fulltext.]

Encapsulation of the BeII cation: Spectroscopic and computational study

The structures of a series of tetracoordinate beryllium(II) complexes with ligands derived from tertiary-substituted amines have been computationally modeled and their 9Be magnetic shielding values determined using the gauge-including atomic orbital (GIAO) method at the 6-311++g(2d,p) level. A good correlation was observed between calculated 9Be NMR chemical shifts when compared to experimental values in polar protic solvents, less so for the values recorded in polar aprotic solvents. A number of alternative complex structures were modeled, resulting in an improvement in experimental versus computational 9Be NMR chemical shifts, suggesting that in some cases full encapsulation on the beryllium atom was not occurring. Several of the synthesized complexes gave rise to unexpected fluorescence, and inspection of the calculated molecular orbital diagrams associated with the electronic transitions suggested that the rigidity imparted by the locking of certain conformations upon BeII coordination allowed delocalization across adjacent aligned aromatic rings bridged by BeII.

Selective alkylation of aminophenols

O-or N-Alkylated derivatives of aminophenols are important synthetic intermediates in organic synthesis. A series of aminophenols were selectively alkylated on their hydroxyl group in good yields via benzaldehyde protection of the amino group, subsequent alkylation, and hydrolysis; or on their amino group via imination and following reduction. ARKAT USA, Inc.

A Facile Reduction Procedure for N,N′-bis[5-Substituted Salicylidene]-m/p-phenylenediamines with Sodium Borohydride-Silica Gel System

An easy approach involving sodium borohydride/silica gel system offers a fast method of reduction for N,N′-bis[5-substituted salicylidene] m/p-phenylenediamines to the corresponding amines with excellent yield. The observed formation of boron chelates in

Esters and Lactones of Phenolic Amino Carboxylic Acids: Prodrugs for Iron Chelation

The new iron chelator N,N'-bis(2-hydroxyphenyl)ethylenediamine-N,N'-diacetic acid (1), its dilactone 2, N,N'-bis(2-hydroxybenzyl)-2-hydroxypropylene-1,3-diamine-N,N'-diacetic acid (3), and its methyl ester lactone 4 and a series of esters of N,N'-bis(2-hy

Method of topically treating inflammation

This invention describes a method of treating inflammation in warmblooded animals by topically administering an effective amount of benzylamine and its derivatives.